These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Surgical therapy for hiliar cholangiocarcinoma: analysis of 198 cases. Zhang BH; Cheng QB; Luo XJ; Zhang YJ; Jiang XQ; Zhang BH; Yi B; Yu WL; Wu MC Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):278-82. PubMed ID: 16698591 [TBL] [Abstract][Full Text] [Related]
24. [Criteria for radical resection of hilar cholangiocarcinoma]. Peng SY; Hong DF Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1123-6. PubMed ID: 20021898 [No Abstract] [Full Text] [Related]
25. [Surgery for hilar cholangiocarcinoma--result and limit of surgical treatment]. Nimura Y Nihon Shokakibyo Gakkai Zasshi; 2001 Mar; 98(3):269-77. PubMed ID: 11280903 [No Abstract] [Full Text] [Related]
26. [Surgical treatment for hilar cholangiocarcinoma]. Arai T; Nagino M; Nimura Y Nihon Rinsho; 2006 Jan; 64 Suppl 1():476-8. PubMed ID: 16457308 [No Abstract] [Full Text] [Related]
27. Cholangiocarcinoma arising from intraductal papillary mucinous neoplasm of the bile duct. Marincola P; Gonzalez RS; Shi C; Poulose B; Parikh A Am Surg; 2015 Mar; 81(3):E102-3. PubMed ID: 25760180 [No Abstract] [Full Text] [Related]
28. Distal cholangiocarcinoma. Liu K J Surg Oncol; 2007 Mar; 95(3):192-3. PubMed ID: 17323332 [No Abstract] [Full Text] [Related]
29. [To further improve the effects of surgical treatment for hilar cholangiocarcinoma]. Chen XP; Huang ZY Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1121-2. PubMed ID: 20021897 [No Abstract] [Full Text] [Related]
31. Management and extent of resection for intrahepatic cholangiocarcinoma. Carpizo DR; D'Angelica M Surg Oncol Clin N Am; 2009 Apr; 18(2):289-305, viii-ix. PubMed ID: 19306813 [TBL] [Abstract][Full Text] [Related]
32. [A case report of cholangiectasis with cholangiocarcinoma]. Nagata T; Ikoma H; Komiyama S; Nishio M; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Otsuji E Gan To Kagaku Ryoho; 2011 Nov; 38(12):2429-32. PubMed ID: 22202403 [TBL] [Abstract][Full Text] [Related]
33. [Comment on "Management of hilar cholangiocarcinoma"]. Launois B J Chir (Paris); 2009 Feb; 146(1):101-2. PubMed ID: 19446704 [No Abstract] [Full Text] [Related]
34. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading. Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982 [TBL] [Abstract][Full Text] [Related]
35. Recurrent cholangiocarcinoma: negative autopsy results after aggressive management. Ashamalla H; Kostandy G; Salama S; Ghaly M; Taha H; Toni E; Sosler B; Chandra P South Med J; 2000 Jun; 93(6):603-5. PubMed ID: 10881779 [TBL] [Abstract][Full Text] [Related]
36. Can Positive Resection Margin of Intra-hepatic Cholangiocarcinoma Still Provide a Survival Benefit over Systemic Chemotherapy? Cucchetti A; Bertuzzo V; Pinna AD World J Surg; 2015 Dec; 39(12):2965-6. PubMed ID: 26467784 [No Abstract] [Full Text] [Related]